From molecular discovery to therapeutic innovation, we combine bioengineering with computational science to develop personalized treatments. Our research integrates genetic analysis, advanced biomarker detection, and quantitative modeling to accelerate the development of precise, effective therapies. See all of our research areas.
Advancing drug discovery and treatment optimization through computational modeling and systems-level analysis of biological processes.
Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.
Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.
Understanding how genetic variation impacts drug response to enable more precise and personalized therapeutic strategies.
$30M
14,000
Pioneering the analysis of over 14,000 biosynthetic gene clusters across 2,500 human-associated bacteria to discover new therapeutic compounds.
46th year
In 2025, and for the 46th consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school.
Education
Seven forward-thinking projects poised to advance the mission of the UCSF School of Pharmacy have been selected to receive support through the 2026 Mary Anne Koda-Kimble Seed Award for Innovation.
Rada Savic, PhD, has been awarded a $30.6M grant over five years from the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for a cooperative agreement establishing a global consortium of tuberculosis (TB) preclinical and clinical experts to research the most effective treatment and testing options.
Su Guo, PhD, professor in the Department of Bioengineering and Therapeutic Sciences, is seeking to expand our understanding of the brain to help treat neuropsychiatric disorders.